88 related articles for article (PubMed ID: 22780906)
61. Cyclopamine-loaded core-cross-linked polymeric micelles enhance radiation response in pancreatic cancer and pancreatic stellate cells.
Zhao J; Wu C; Abbruzzese J; Hwang RF; Li C
Mol Pharm; 2015 Jun; 12(6):2093-100. PubMed ID: 25936695
[TBL] [Abstract][Full Text] [Related]
62. Core-shell nanoparticulate formulation of gemcitabine: lyophilization, stability studies, and in vivo evaluation.
Chitkara D; Mittal A; Mahato RI; Kumar N
Drug Deliv Transl Res; 2014 Dec; 4(5-6):439-51. PubMed ID: 25787206
[TBL] [Abstract][Full Text] [Related]
63. Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy.
Pandolfi S; Stecca B
Expert Rev Mol Med; 2015 Feb; 17():e5. PubMed ID: 25660620
[TBL] [Abstract][Full Text] [Related]
64. Chemoradiation therapy using cyclopamine-loaded liquid-lipid nanoparticles and lutetium-177-labeled core-crosslinked polymeric micelles.
You J; Zhao J; Wen X; Wu C; Huang Q; Guan F; Wu R; Liang D; Li C
J Control Release; 2015 Mar; 202():40-8. PubMed ID: 25637565
[TBL] [Abstract][Full Text] [Related]
65. Polymeric micelles for multi-drug delivery in cancer.
Cho H; Lai TC; Tomoda K; Kwon GS
AAPS PharmSciTech; 2015 Feb; 16(1):10-20. PubMed ID: 25501872
[TBL] [Abstract][Full Text] [Related]
66. Regulation of sonic hedgehog expression by integrin β1 and epidermal growth factor receptor in intestinal epithelium.
Xu C; Li X; Topham MK; Kuwada SK
IUBMB Life; 2014 Oct; 66(10):694-703. PubMed ID: 25355554
[TBL] [Abstract][Full Text] [Related]
67. Multifunctional nanoparticles for prostate cancer therapy.
Chandratre SS; Dash AK
AAPS PharmSciTech; 2015 Feb; 16(1):98-107. PubMed ID: 25190362
[TBL] [Abstract][Full Text] [Related]
68. LHRH-conjugated micelles for targeted delivery of antiandrogen to treat advanced prostate cancer.
Wen D; Chitkara D; Wu H; Danquah M; Patil R; Miller DD; Mahato RI
Pharm Res; 2014 Oct; 31(10):2784-95. PubMed ID: 24789451
[TBL] [Abstract][Full Text] [Related]
69. Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer.
Onishi H; Katano M
World J Gastroenterol; 2014 Mar; 20(9):2335-42. PubMed ID: 24605030
[TBL] [Abstract][Full Text] [Related]
70. The Hedgehog inhibitor cyclopamine antagonizes chemoresistance of breast cancer cells.
Chai F; Zhou J; Chen C; Xie S; Chen X; Su P; Shi J
Onco Targets Ther; 2013; 6():1643-7. PubMed ID: 24250231
[TBL] [Abstract][Full Text] [Related]
71. BSA-PLGA-based core-shell nanoparticles as carrier system for water-soluble drugs.
Chitkara D; Kumar N
Pharm Res; 2013 Sep; 30(9):2396-409. PubMed ID: 23756758
[TBL] [Abstract][Full Text] [Related]
72. Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines.
Pino MS; Shrader M; Baker CH; Cognetti F; Xiong HQ; Abbruzzese JL; McConkey DJ
Cancer Res; 2006 Apr; 66(7):3802-12. PubMed ID: 16585207
[TBL] [Abstract][Full Text] [Related]
73. Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer.
Xu FG; Ma QY; Wang Z
Cancer Lett; 2009 Oct; 283(2):119-24. PubMed ID: 19232458
[TBL] [Abstract][Full Text] [Related]
74. Therapeutic Potential of Steroidal Alkaloids in Cancer and Other Diseases.
Jiang QW; Chen MW; Cheng KJ; Yu PZ; Wei X; Shi Z
Med Res Rev; 2016 Jan; 36(1):119-43. PubMed ID: 25820039
[TBL] [Abstract][Full Text] [Related]
75. Micellar delivery of cyclopamine and gefitinib for treating pancreatic cancer.
Chitkara D; Singh S; Kumar V; Danquah M; Behrman SW; Kumar N; Mahato RI
Mol Pharm; 2012 Aug; 9(8):2350-7. PubMed ID: 22780906
[TBL] [Abstract][Full Text] [Related]
76. Coadministration of Polymeric Conjugates of Docetaxel and Cyclopamine Synergistically Inhibits Orthotopic Pancreatic Cancer Growth and Metastasis.
Almawash SA; Mondal G; Mahato RI
Pharm Res; 2018 Jan; 35(1):17. PubMed ID: 29305793
[TBL] [Abstract][Full Text] [Related]
77. Copolymeric micelles for delivery of EGCG and cyclopamine to pancreatic cancer cells.
Sun L; Zhang C; Li P
Nutr Cancer; 2014; 66(5):896-903. PubMed ID: 24798568
[TBL] [Abstract][Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
